CarMax (KMX US)
KMX US$53.99
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 53.99
- Change
- ▲ 0.10 (0.19)
- Bid / Ask
- 0.00 - 0.00
- Volume
- 569,621
- Turnover
- 28,324,095
- Open
- 53.78
- Day Range
- 53.13 - 54.09
- VWAP
- 53.93
- Prev Close
- 53.89
- Last Trade
- 28/10 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Consumer Cyclical
- Shares Issued
- 141,942,807
- NTA/Share
- 41.53
- Last Dividend
- —
- Dividend Ex Date
- —
- Dividend Pay Date
- —
Current (USD) · FY2026
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 25,881.13
- EBITDA
- -255.21
- Profit
- 247.29
- Earnings Per Share (EPS)
- 1.68
- Dividend Per Share (DPS)
- —
- Yield %
- 0.00
- Market Cap
- 7,663.49
- Price to Earnings Ratio (P/E)
- 25.47
Estimates (USD) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 28,058.46
- EBITDA
- 1,026.15
- Profit
- 436.15
- Earnings Per Share (EPS)
- 2.91
- Dividend Per Share (DPS)
- 0.00
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- Narrow
- Financial Health
- Moderate
- Uncertainty
- High
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 69.09 Fair value 90.16 One-star price 117.66
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 90.16
- Price / Fair Value
- 0.60
- Valuation
- Undervalued
- Uncertainty
- High
Morningstar Quantitative Rating as of 28 OCT 2026. The slider runs from the five-star price (69.09) to the one-star price (117.66).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 53.99 |
| Price - 12 month high | 65.28 |
| Price - 12 month low | 30.26 |
| Pricing date | 27 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 2.83 |
| Market capitalization | 7,663.49 |
| 12 Month High price date | 26 AUG 2026 |
| 12 Month Low price date | 6 NOV 2025 |
| Volume - avg. trading volume for the last 3 months | 2.56 |
| Price - 1 Day % Change | 0.19% |
| Price - 13 week price percent change | -8.31% |
| Price - 26 week price percent change | 39.73% |
| Price - 5 Day % Change | 4.86% |
| Price - 52 week price percent change | 21.46% |
| Price - YTD price percent change | 37.34% |
| Price % Change Month To Date | -4.53% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 1.680 |
| EPS excluding extraordinary items - trailing 12 month | 2.120 |
| EPS Normalized - most recent fiscal year | 2.910 |
| Revenue/share - most recent fiscal year | 175.331 |
| Revenue/share - trailing 12 month | 192.954 |
| Book value per share - most recent fiscal year | 41.530 |
| Book value per share - most recent quarter | 44.419 |
| Book value (tangible) per share - most recent fiscal year | 41.530 |
| Book value (tangible) per share - most recent quarter | 44.419 |
| Cash per share - most recent fiscal year | 0.866 |
| Cash per share - most recent quarter | 1.201 |
| Cash Flow per share - most recent fiscal year | 15.531 |
| Cash Flow per share - trailing 12 month | 19.729 |
| Dividend per share - most recent fiscal year | — |
| Dividends per share - trailing 12 month | 0.000 |
| EBITD per share - trailing 12 month | -0.848 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 1.680 |
| EPS Basic excluding extraordinary items - trailing 12 month | 2.110 |
| EPS including extraordinary items - most recent fiscal year | 1.680 |
| EPS including extraordinary items - trailing 12 month | 2.050 |
| Free Cash Flow per share - trailing 12 month | 16.564 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 25.59 |
| P/E Normalized, most recent fiscal year | 15.15 |
| Price to sales - most recent fiscal year | 0.28 |
| Price to Tangible Book - most fiscal year | 1.22 |
| Price to Free Cash Flow per Share - most recent fiscal year | 3.26 |
| Price to Cash Flow per share - trailing 12 month | 2.74 |
| Price to Book - most recent fiscal year | 1.22 |
| P/E excluding extraordinary items high, trailing 12 months | 40.39 |
| P/E excluding extraordinary items low, trailing 12 months | 9.03 |
| Net Debt, LFI | 17,700.71 |
| Net Debt, LFY | 18,421.73 |
| Dividend Yield - 5 Year Average | — |
| Dividend Yield - indicated annual dividend divided by closing price | — |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 0.00% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 1,751.64 |
| LT debt/equity - most recent fiscal year | 301.00% |
| Payout ratio - most recent fiscal year | — |
| Total debt/total equity - most recent fiscal year | 314.91% |
| LT debt/equity - most recent quarter | 273.21% |
| Total debt/total equity - most recent quarter | 283.47% |
| Free Cash Flow - trailing 12 month | 2,372.05 |
| Payout ratio - trailing 12 month | — |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 25,881.13 |
| Revenue - trailing 12 month | 27,631.34 |
| EBITD - most recent fiscal year | -255.21 |
| EBITD - trailing 12 month | -121.41 |
| Earnings before taxes - most recent fiscal year | 383.43 |
| Earnings before taxes - trailing 12 month | 454.83 |
| Net Income available to common - most recent fiscal year | 247.29 |
| Net Income available to common - trailing 12 months | 292.45 |
| Earnings before taxes Normalized - most recent fiscal year | 623.71 |
| Net Income Available to Common, Normalized - most recent fiscal year | — |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 3.56 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 0.96% |
| Net Profit Margin % - trailing 12 month | 1.06% |
| Operating margin - 1st historical fiscal year | -1.58% |
| Operating margin - trailing 12 month | -1.40% |
| Pretax margin - trailing 12 month | 1.65% |
| Pretax margin - 1st historical fiscal year | 1.48% |
| Operating Margin - 5 year average | -0.50% |
| Pretax Margin - 5 year average | 2.65% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 4.17% |
| Free Operating Cash Flow/Revenue, TTM | 8.58% |
| Net Profit Margin - 5 year average | 1.98% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 0.92% |
| Return on average assets - trailing 12 month | 1.11% |
| Return on average equity - most recent fiscal year | 4.03% |
| Return on average equity - trailing 12 month | 4.78% |
| Return on average assets - 5 year average | 2.16% |
| Return on average equity - 5 year average | 10.16% |
| Net Income/employee - most recent fiscal year | 8,896.60 |
| Revenue/employee - most recent fiscal year | 931,109.91 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 6.43% |
| EPS growth rate, 5 year | -17.96% |
| Growth rate% - dividend, 3 year | — |
| Revenue/share (5 yr growth) | 8.85% |
| Growth rate% - Revenue, 3 year | -4.47% |
| Growth rate% - EPS, 3 year | -17.85% |
| Book value per share growth rate, 5 year | 9.20% |
| Capital Spending growth rate, 5 year | 26.88% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | — |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2026 | 2027 | 2028 | 2029 | |||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | FEB 22 | FEB 23 | FEB 24 | FEB 25 | FEB 26 |
| Fiscal year: | 2022 | 2023 | 2024 | 2025 | 2026 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
CarMax sells, finances, and services used and new cars through a chain of over 255 retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales were 80% of fiscal 2026 revenue and wholesale about 17%, with the remaining portion composed of extended service plans and repair. In fiscal 2026, the company retailed and wholesaled 780,684 and 538,203 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US, but still estimates that it had only about 3.6% US market share of vehicles zero to 10 years old in calendar 2025. CarMax is based in Richmond, Virginia.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
